<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-02-28</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-02-28</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>56</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
Deconvolution of regulatory T cell heterogeneity identifies cycling precursors as conductors of immune escape during breast carcinoma progressionï¼Œæ­ç¤ºäº†Tregå¼‚è´¨æ€§ä¸è‚¿ç˜¤å…ç–«é€ƒé€¸çš„æ–°æœºåˆ¶ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒè°ƒæ§</strong>ï¼šNKG2AæŠ‘åˆ¶ä¿ƒè¿›NKä¸CD8+ Tç»†èƒç›¸äº’ä½œç”¨ï¼Œå¢å¼ºåµå·¢ç™Œå…ç–«ï¼›M1å·¨å™¬ç»†èƒå¤–æ³Œä½“å¢å¼ºTNBCå…ç–«ç–—æ•ˆã€‚<br />
*   <strong>è‚¿ç˜¤å‘ç”Ÿä¸è¿›å±•æœºåˆ¶</strong>ï¼šDKC1ä¿ƒè¿›ç»“ç›´è‚ ç™Œè¿›å±•ä¸è€è¯ï¼›CHD1æ˜¯MYCé©±åŠ¨ä¹³è…ºç™Œçš„åˆæˆè‡´æ­»é¶ç‚¹ï¼›è¶…å¢å¼ºå­å˜å¼‚è°ƒæ§LINC00636å’ŒCD47åœ¨ä¹³è…ºç™Œä¸­çš„ä½œç”¨ã€‚<br />
*   <strong>ç¥ç»æ¯ç»†èƒç˜¤æ²»ç–—</strong>ï¼šUSP7æŠ‘åˆ¶è¯±å¯¼PRC1.1å¤åˆç‰©å¤±ç¨³ï¼Œä¿ƒè¿›ç¥ç»æ¯ç»†èƒç˜¤ç¥ç»åˆ†åŒ–ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šæ•´åˆæ‹·è´æ•°ã€ç”²åŸºåŒ–å’Œèåˆæ£€æµ‹ï¼Œé€šè¿‡Nanoporeæµ‹åºæ”¹è¿›å„¿ç«¥åŠæˆäººç½•è§è‚¿ç˜¤è¯Šæ–­ã€‚<br />
*   <strong>å•ç»†èƒä¸ç©ºé—´è½¬å½•ç»„å­¦</strong>ï¼šåº”ç”¨äºå¤šç§ç™Œç—‡ï¼ˆå¦‚åµå·¢ç™Œã€å£è…”é³çŠ¶ç»†èƒç™Œã€ä¹³è…ºç™Œï¼‰å’Œå™¨å®˜ï¼ˆè‚è„ï¼‰çš„å¾®ç¯å¢ƒä¸å‘è‚²ç ”ç©¶ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç»†èƒå†…ç”Ÿç‰©åˆ†å­å‡èšä½“è¢«å‘ç°å…·æœ‰éšè—çš„è›‹ç™½è´¨éª¨æ¶ç»“æ„ï¼Œä¸ºç™Œç—‡å’ŒALSç­‰ç–¾ç—…çš„æ²»ç–—å¼€è¾Ÿæ–°é¶ç‚¹ï¼›å¯¹è¡°è€çš„ææƒ§å’ŒPFASåŒ–å­¦ç‰©è´¨çš„æš´éœ²å‡è¢«è¯å®åŠ é€Ÿç»†èƒå±‚é¢çš„ç”Ÿç‰©å­¦è¡°è€ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢ç”Ÿç‰©åˆ†å­å‡èšä½“å†…éƒ¨çš„è›‹ç™½è´¨éª¨æ¶ç»“æ„åŠå…¶åœ¨ç–¾ç—…å‘ç”Ÿä¸­çš„ä½œç”¨ã€‚<br />
- ç ”ç©¶å¿ƒç†å› ç´ ï¼ˆå¦‚å¯¹è¡°è€çš„ææƒ§ï¼‰å¯¹ç”Ÿç†è¡°è€è¿‡ç¨‹çš„å½±å“ã€‚<br />
- è¯„ä¼°å…¨æ°Ÿå’Œå¤šæ°Ÿçƒ·åŸºç‰©è´¨ï¼ˆPFASï¼‰å¯¹ç”Ÿç‰©å­¦è¡°è€é€Ÿåº¦çš„å½±å“ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- æ­ç¤ºäº†ç»†èƒå†…ç”Ÿç‰©åˆ†å­å‡èšä½“å¹¶éç®€å•æ¶²æ»´ï¼Œè€Œæ˜¯å­˜åœ¨ç²¾å¯†çš„å†…éƒ¨è›‹ç™½è´¨éª¨æ¶ã€‚<br />
- é€šè¿‡å¯¹700å¤šåå¥³æ€§çš„ç ”ç©¶ï¼Œé‡åŒ–äº†å¯¹è¡°è€ææƒ§å¯¹ç»†èƒè¡°è€é€Ÿåº¦çš„å½±å“ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (53æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE320142 NKG2AæŠ‘åˆ¶ä¿ƒè¿›NKç»†èƒ-CD8+ Tç»†èƒç›¸äº’ä½œç”¨ï¼Œä»è€Œå¢å¼ºåµå·¢ç™Œçš„æŠ—ç™Œå…ç–«åŠ›</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€immunityã€T cellã€NK cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Teraza Lanickova ; Artemis Angelidou ; Michal Hensler ; Veronika Niederlova ; Jitka FucikovaSeries Type : OtherOrganism : Homo sapiensNatural killer (NK) cells contribute to tumor immunosurveillance, yet their phenotypic and functional heterogeneity and impact on anti-tumor immunity remain incompletely understood. Here, using an integrated set of transcriptomic, spatial, and functional assays, we demonstrate that advanced non-small cell lung carcinoma (NSCLC), which is generally considered an immunologically â€œhotâ€ tumor â€“ contains elevated levels of intratumoral cytotoxic NK1 (CD56dim) and NK3 subsets, which exhibit robust clinically relevant effector functions, localze preferentially within tumor cores, and spatially interact with CD8+ T cells in mature tertiary lymphoid structures (mTLSs). In contrast, the NK cell compartment of immunological â€œcoldâ€ tumors such as high-grade serous ovarian carcinoma (HGSOC) â€“ which generally contains immature TLSs and ICI-resistant TCF1-TIM3+CD8+ CTLs â€“ is enriched in functionally exhausted NK2 (CD56bright) NK cells expressing high levels of TIM3 and NKG2A. Functional studies in HGSOC patient samples and syngeneic mouse models reveal that bidirectional crosstalk between NK cells and CD8âº T cells is essential for anti-tumor immunity, and that disrupting this interactionâ€”via CD8âº T cell or NK cell depletionâ€”promotes NK cell exhaustion and CD8âº T cell dysfunction. Importantly, blockade of NKG2A restores NK cytotoxicity and promotes CD8âº T cell effector responses, and when combined with PD1 inhibition, significantly enhances survival in murine HGSOC models. Our findings highlight the NKG2Aâ€“HLA-E axis as a clinically actionable checkpoint in tumors with impaired NK cellâ€“mediated immunity, and delineate the spatial and functional interplay between NK cells and CD8âº T cells as a determinant of anti-tumor immune efficacy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320142" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE253585 è°ƒèŠ‚æ€§ T ç»†èƒå¼‚è´¨æ€§çš„è§£å·ç§¯æ­ç¤ºäº†å¾ªç¯å‰ä½“ç»†èƒåœ¨ä¹³è…ºç™Œè¿›å±•è¿‡ç¨‹ä¸­ä½œä¸ºå…ç–«é€ƒé€¸çš„ä¼ å¯¼è€… [Visium]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€immuneã€T cellã€Visium<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Triet Bui ; Ernesto Rojas ; Julieann Puleo ; Aashna Jhaveri ; Simona Cristea ; Franziska Michor ; Kornelia PolyakSeries Type : OtherOrganism : Rattus norvegicusTumor-immune microenvironment is instrumental in shaping breast cancer tumor evolution. We previously identified an evolutionary bottleneck demarcating ductal carcinoma in situ (DCIS) from invasive ductal carcinoma (IDC). How the microenvironment evolves during such transition remains elusive. We dissected, in parallel, single-cell composition of DCIS and IDC patients and rat tumors that faithfully recapitulate human breast cancer. We discovered T cell diversity distinguishing DCIS and IDC and a novel cycling Treg state occupying the pseudotime bifurcation between DCIS and IDC, preceding more activated Treg subtypes. Multiscale analysis of patient cohorts as part of HTAN Consortium established that cycling Treg predicts recurrence in low-grade DCIS. We proved cycling Treg as Treg progenitors critical for immune escape and demonstrated that OX40 agonism restored immunotherapeutic sensitivity, where responders displayed increased inflammatory CAF subtype heterogeneity. Our study thus established cycling Tregâ€™s importance in preserving immune escape and underscored its prognostic value to stratify future recurrence.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253585" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE310797 ä¸åŒåˆ†æœŸå£è…”é³çŠ¶ç»†èƒç™Œçš„å•ç»†èƒå’Œç©ºé—´RNAæµ‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€RNA-seqã€spatial<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Fengtian Li ; Hu ChenSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiensTo investigate the dynamic changes in the tumor microenvironment during the progression of oral squamous cell carcinoma (OSCC), we collected 16 treatment-naÃ¯ve OSCC samples for single-cell RNA sequencing (scRNA-seq). Among these, 6 cases were additionally subjected to spatial transcriptomic profiling to capture the tissue architecture and spatial organization of the tumor microenvironment.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310797" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE312050 å¯¹è°ƒèŠ‚æ€§ T ç»†èƒå¼‚è´¨æ€§çš„è§£å·ç§¯åˆ†æè¡¨æ˜ï¼Œå¢æ®–å‰ä½“ç»†èƒæ˜¯ä¹³è…ºç™Œè¿›å±•è¿‡ç¨‹ä¸­å…ç–«é€ƒé€¸çš„è°ƒæ§è€…</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€immuneã€T cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Triet Bui ; Ernesto Rojas ; Julieann Puleo ; Simona Cristea ; Franziska Michor ; Kornelia PolyakSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusTumor-immune microenvironment is instrumental in shaping breast cancer tumor evolution. We previously identified an evolutionary bottleneck demarcating ductal carcinoma in situ (DCIS) from invasive ductal carcinoma (IDC). How the microenvironment evolves during such transition remains elusive. We dissected, in parallel, single-cell composition of DCIS and IDC patients and rat tumors that faithfully recapitulate human breast cancer. We discovered T cell diversity distinguishing DCIS and IDC and a novel cycling Treg state occupying the pseudotime bifurcation between DCIS and IDC, preceding more activated Treg subtypes. Multiscale analysis of patient cohorts as part of HTAN Consortium established that cycling Treg predicts recurrence in low-grade DCIS. We proved cycling Treg as Treg progenitors critical for immune escape and demonstrated that OX40 agonism restored immunotherapeutic sensitivity, where responders displayed increased inflammatory CAF subtype heterogeneity. Our study thus established cycling Tregâ€™s importance in preserving immune escape and underscored its prognostic value to stratify future recurrence.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312050" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE253587 å¯¹è°ƒèŠ‚æ€§ T ç»†èƒå¼‚è´¨æ€§çš„è§£å·ç§¯æ­ç¤ºäº†å¾ªç¯å‰ä½“ç»†èƒåœ¨ä¹³è…ºç™Œè¿›å±•è¿‡ç¨‹ä¸­å…ç–«é€ƒé€¸çš„è°ƒæ§ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€immuneã€T cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiens ; Rattus norvegicusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253587" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE253572 å¯¹è°ƒèŠ‚æ€§ T ç»†èƒå¼‚è´¨æ€§çš„è§£å·ç§¯æ­ç¤ºäº†å¾ªç¯å‰ä½“ç»†èƒåœ¨ä¹³è…ºç™Œè¿›å±•è¿‡ç¨‹ä¸­å…ç–«é€ƒé€¸çš„è°ƒæ§ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€immuneã€T cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Triet Bui ; Ernesto Rojas ; Julieann Puleo ; Simona Cristea ; Franziska Michor ; Kornelia PolyakSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiens ; Rattus norvegicusTumor-immune microenvironment is instrumental in shaping breast cancer tumor evolution. We previously identified an evolutionary bottleneck demarcating ductal carcinoma in situ (DCIS) from invasive ductal carcinoma (IDC). How the microenvironment evolves during such transition remains elusive. We dissected, in parallel, single-cell composition of DCIS and IDC patients and rat tumors that faithfully recapitulate human breast cancer. We discovered T cell diversity distinguishing DCIS and IDC and a novel cycling Treg state occupying the pseudotime bifurcation between DCIS and IDC, preceding more activated Treg subtypes. Multiscale analysis of patient cohorts as part of HTAN Consortium established that cycling Treg predicts recurrence in low-grade DCIS. We proved cycling Treg as Treg progenitors critical for immune escape and demonstrated that OX40 agonism restored immunotherapeutic sensitivity, where responders displayed increased inflammatory CAF subtype heterogeneity. Our study thus established cycling Tregâ€™s importance in preserving immune escape and underscored its prognostic value to stratify future recurrence.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253572" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE317253 å¢å¼ºçš„çº¿ç²’ä½“è‡ªå™¬é€šè¿‡æ¢å¤ä¸Šçš®ä»£è°¢é€‚åº”æ€§ä¿ƒè¿›è‚ºä¿®å¤å’Œå†ç”Ÿ [AT2s RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolicã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ying Xi ; Pei Wu ; Jiawei ChenSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAlveolar Type II cells (AT2s) are the stem cells in the alveoli, responsible for both alveolar homeostasis and regeneration. Mitochondrial dysfunction has been reported in the AT2 cells from both chronic and acute injury induced alveolar diseases, including idiopathic pulmonary fibrosis (IPF) and viral pneumonia. Here, we demonstrate that genetic depletion of Ubiquitin Specific Peptidase 30 (USP30), a negative regulator of mitophagy, boosts mitophagy and restores mitochondrial function, leading to protection from injury induced AT2 apoptosis and increased AT2 stem cell activity. Both global Usp30 knockout (KO) and AT2-specific Usp30 KO protects the mice from bleomycin induced lung fibrosis and influenza puneumonia. Moreover, pharmaceutical inhibition of USP30 using a small molecule inhibitor effectively alleviates lung fibrosis and influenza pneumonia. Our study underscores a therapeutic potiential of USP30 inhibition for the treatment of injury induced alveolar diseases, offering a promising strategy for treating injury induced diseases<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317253" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE317252 å¢å¼ºçš„çº¿ç²’ä½“è‡ªå™¬é€šè¿‡æ¢å¤ä¸Šçš®ä»£è°¢é€‚åº”æ€§ä¿ƒè¿›è‚ºä¿®å¤å’Œå†ç”Ÿ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolicã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ying Xi ; Pei Wu ; Jiawei ChenSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAlveolar Type II cells (AT2s) are the stem cells in the alveoli, responsible for both alveolar homeostasis and regeneration. Mitochondrial dysfunction has been reported in the AT2 cells from both chronic and acute injury induced alveolar diseases, including idiopathic pulmonary fibrosis (IPF) and viral pneumonia. Here, we demonstrate that genetic depletion of Ubiquitin Specific Peptidase 30 (USP30), a negative regulator of mitophagy, boosts mitophagy and restores mitochondrial function, leading to protection from injury induced AT2 apoptosis and increased AT2 stem cell activity. Both global Usp30 knockout (KO) and AT2-specific Usp30 KO protects the mice from bleomycin induced lung fibrosis and influenza puneumonia. Moreover, pharmaceutical inhibition of USP30 using a small molecule inhibitor effectively alleviates lung fibrosis and influenza pneumonia. Our study underscores a therapeutic potiential of USP30 inhibition for the treatment of injury induced alveolar diseases, offering a promising strategy for treating injury induced diseases<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317252" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE320329 å¯¹åœŸå£¤å¾®ç”Ÿç‰©ç¾¤è½çš„å¤šç»„å­¦è¡¨å¾æ­ç¤ºäº†ç¥ç€é…¸å’Œè°·æ°¨é…¸ä»£è°¢åœ¨ç¢³é…¸é’™æ²‰æ·€è¿‡ç¨‹ä¸­çš„å…³é”®ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:micro(b|be|bial|organism)ã€metabolism<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lin Tesia T. ; Anthony Winston ; McClure Ryan ; Mitchell HughSeries Type : Expression profiling by high throughput sequencingOrganism : Bacillus toyonensis ; Curtobacterium flaccumfaciens ; Microbacterium foliorum ; Rhodococcus qingshengiiMicrobially induced calcium carbonate precipitation (MICP) holds potential for soil stabilization and carbon sequestration efforts. While the biogeochemical pathways and enzymes driving MICP are known, the microbial metabolic networks and community dynamics underlying such processes remain poorly characterized. To address this gap, we interrogated a MICP-capable four-member consortium of soil bacteria termed carbon storing consortium - A (CSC-A). Prior work shows that CSC-A yields carbonate at a higher quantity compared to the sum of carbonate individually produced by each member, suggesting MICP is driven by consortium dynamics.Thus, we applied a multi-omic integration approach of genomics, transcriptomics, and metabolomics to investigate potential inter-species interactions that may influence the MICP phenotype. Genomic life history characterizations identified evidence of specialization by two members, while metatranscriptomic perturbation suggested that R. qingshengii is a keystone species when grown in urea, a key molecule to the MICP process. By comparing individual speciesâ€™ metabolomes to the metabolic profile of a shared well, we identified over 200 metabolites predicted to be produced or consumed by CSC-A. Integrating both data types and mapping them to the KEGG reactome highlighted over 20 different enriched pathways with reactions related to glutamate metabolism, succinate metabolism, and branched chain amino acid biosynthesis. As succinate metabolism was a major node in this network we applied laboratory assays to confirm that succinate led to increased carbonate precipitation by CSC-A, a critical validation of our modeling approach. By isolating and identifying the interconnected metabolic components underlying MICP in CSC-A, we identified keystone taxa, metabolites, and pathways important for future optimization of the application of this consortium to carbonate precipitation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320329" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE315997 é€šè¿‡ USP7 æŠ‘åˆ¶å¯¼è‡´éç»å…¸ PRC1.1 å¤åˆç‰©ä¸ç¨³å®šï¼Œä»è€Œè¯±å¯¼ç¥ç»æ¯ç»†èƒç˜¤ä¸­çš„ç¥ç»å…ƒåˆ†åŒ– [CHIP-Seqã€CUT&amp;RUNã€PCGF1KO]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šNeuronalã€ChIP-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Nathaniel W MabeSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensPediatric cancers are frequently driven by genomic alterations that result in impaired differentiation during tissue development. To identify protein complex-level dependencies required for differentiation in neuroblastoma, a pediatric cancer of the developing peripheral nervous system, we curated a list of protein complexes using the CORUM database and mined the Dependency Map (DepMap) using single sample gene set enrichment analysis. This analysis identified the non-canonical PRC1.1 complex, which represses transcriptional activity through ubiquitination of histone 2A, lysine 119 (H2AK119Ub), as a selectively enriched dependency in neuroblastoma. Knockout of several PRC1.1 subunits reduced neuroblastoma growth, arrested the cell cycle, and induced a neuronal differentiation program. While no known direct inhibitors of PRC1.1 exist, co-dependency analysis of PRC1.1 subunits against all other genes in DepMap identified that the deubiquitinase USP7 strongly correlated with PRC1.1 dependency. Treatment with XL177A, a small molecule inhibitor of USP7, significantly reduced neuroblastoma growth in both cellular and animal models. Integrated RNA- and ChIP-sequencing showed that both PRC1.1 knockout and USP7 inhibition resulted in highly correlated transcriptional alterations and reduced H2AK119Ub deposition on chromatin, suggesting that USP7 inhibition reduced neuroblastoma growth through a PRC1.1-dependent mechanism. Mechanistically, global proteomics and ubiquitinomics revealed that USP7 inhibition disrupted non-canonical PRC1 complex assembly, resulting in destabilization of PRC1.1 and subsequent proteolysis. Our findings expand our understanding of the chromatin complexes required to maintain a de-differentiated state in neuroblastoma and suggest the therapeutic potential for USP7 inhibitors in the treatment of this disease.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315997" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 43 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ç»†èƒæ¶²æ»´å†…éƒ¨çš„éšè—ç»“æ„ä¸ºç™Œç—‡å’Œè‚Œèç¼©ä¾§ç´¢ç¡¬åŒ–ç—‡çš„æ²»ç–—å¼€è¾Ÿäº†æ–°çš„é¶ç‚¹ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šBiomolecular condensates were long believed to be simple liquid blobs inside cells. Researchers have now uncovered that some are actually supported by fine protein filaments forming an internal scaffold. When this structure is disrupted, cells fail to grow and divide properly. The discovery suggests scientists may one day design drugs that target condensate architecture to fight cancer and neurodegenerative disease.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260226042447.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>ä½ è¶Šå®³æ€•è¡°è€ï¼Œä½ çš„èº«ä½“è¡°è€çš„é€Ÿåº¦å¯èƒ½å°±è¶Šå¿«ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šaging<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šWorrying about getting olderâ€”especially fearing future health problemsâ€”may actually speed up aging at the cellular level, according to new research from NYU. In a study of more than 700 women, those who felt more anxious about aging showed signs of faster biological aging in their blood, measured using cutting-edge â€œepigenetic clocks.â€ Fears about declining health had the strongest link, while concerns about beauty or fertility didnâ€™t appear to have the same biological impact.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260225081205.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>å¤§å¤šæ•°ç¾å›½äººä½“å†…å‘ç°çš„ PFAS ä¸ç”Ÿç‰©ä½“å¿«é€Ÿè¡°è€æœ‰å…³ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šaging<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šâ€œForever chemicalsâ€ known as PFAS have quietly infiltrated everything from nonstick pans to food packagingâ€”and now new research suggests some of them may be speeding up the aging process itself. In a nationally representative U.S. study, two lesser-known PFAS compounds, PFNA and PFOSA, were found in 95% of participants and strongly linked to faster biological aging in men aged 50 to 64.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260226042449.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>RNA-seq</td>
<td>14</td>
</tr>
<tr>
<td>cancer</td>
<td>9</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>7</td>
</tr>
<tr>
<td>carcinoma</td>
<td>6</td>
</tr>
<tr>
<td>T cell</td>
<td>5</td>
</tr>
<tr>
<td>Neuronal</td>
<td>5</td>
</tr>
<tr>
<td>immune</td>
<td>5</td>
</tr>
<tr>
<td>metabolic</td>
<td>4</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>4</td>
</tr>
<tr>
<td>sequencing</td>
<td>3</td>
</tr>
<tr>
<td>single-cell</td>
<td>2</td>
</tr>
<tr>
<td>macrophage</td>
<td>2</td>
</tr>
<tr>
<td>aging</td>
<td>2</td>
</tr>
<tr>
<td>inflammation</td>
<td>2</td>
</tr>
<tr>
<td>immunity</td>
<td>1</td>
</tr>
<tr>
<td>NK cell</td>
<td>1</td>
</tr>
<tr>
<td>spatial</td>
<td>1</td>
</tr>
<tr>
<td>tumor</td>
<td>1</td>
</tr>
<tr>
<td>regex:micro(b</td>
<td>be</td>
</tr>
<tr>
<td>metabolism</td>
<td>1</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (43æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315996" target="_blank" rel="noopener noreferrer">GSE315996 é€šè¿‡ USP7 æŠ‘åˆ¶å¯¼è‡´éç»å…¸ PRC1.1 å¤åˆç‰©ä¸ç¨³å®šï¼Œä»è€Œè¯±å¯¼ç¥ç»æ¯ç»†èƒç˜¤ç¥ç»å…ƒåˆ†åŒ– [ChIP-Seq NGP]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307922" target="_blank" rel="noopener noreferrer">GSE307922 é€šè¿‡ USP7 æŠ‘åˆ¶å¯¼è‡´éç»å…¸ PRC1.1 å¤åˆç‰©ä¸ç¨³å®šï¼Œä»è€Œè¯±å¯¼ç¥ç»æ¯ç»†èƒç˜¤ä¸­çš„ç¥ç»å…ƒåˆ†åŒ– [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307920" target="_blank" rel="noopener noreferrer">GSE307920 é€šè¿‡ USP7 æŠ‘åˆ¶å¯¼è‡´éç»å…¸ PRC1.1 å¤åˆç‰©ä¸ç¨³å®šï¼Œä»è€Œè¯±å¯¼ç¥ç»æ¯ç»†èƒç˜¤ä¸­çš„ç¥ç»å…ƒåˆ†åŒ– [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303748" target="_blank" rel="noopener noreferrer">GSE303748 CHD1 æ˜¯ MYC é©±åŠ¨çš„ä¹³è…ºç™Œä¸­çš„åˆæˆè‡´æ­»è„†å¼±æ€§ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303747" target="_blank" rel="noopener noreferrer">GSE303747 CHD1 æ˜¯ MYC é©±åŠ¨çš„ä¹³è…ºç™Œä¸­çš„åˆæˆè‡´æ­»è„†å¼±æ€§ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291677" target="_blank" rel="noopener noreferrer">GSE291677 ä¹³é…¸å’Œç»„è›‹ç™½H3K18ä¹³åŒ–ä¸è§†ç½‘è†œåŸºå› è¡¨è¾¾çš„ä»£è°¢è°ƒæ§ç›¸å…³</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290710" target="_blank" rel="noopener noreferrer">GSE290710 ä¹³è…ºç™Œä¸­ LINC00636 å’Œ CD47 è°ƒæ§çš„åŒåŠŸèƒ½è¶…çº§å¢å¼ºå­å†…çš„ InDel åŸºå› ç»„å˜å¼‚ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290709" target="_blank" rel="noopener noreferrer">GSE290709 ä¹³è…ºç™Œä¸­ LINC00636 å’Œ CD47 è°ƒæ§çš„åŒåŠŸèƒ½è¶…çº§å¢å¼ºå­å†…çš„ InDel åŸºå› ç»„å˜å¼‚ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320584" target="_blank" rel="noopener noreferrer">GSE320584 åˆ©ç”¨ STEMdiffâ„¢ è‚ç±»å™¨å®˜ç”Ÿé•¿åŸ¹å…»åŸºå’Œ STEMdiffâ„¢ è‚ç±»å™¨å®˜åˆ†åŒ–åŸ¹å…»åŸºï¼Œå¯¹ hPSC æ¥æºçš„è‚ç»†èƒæ ·ç»†èƒç”Ÿæˆçš„å¢æ®–æ€§å’Œåˆ†åŒ–æ€§è‚ç±»å™¨å®˜è¿›è¡Œå•ç»†èƒ RNA æµ‹åºåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320206" target="_blank" rel="noopener noreferrer">GSE320206 é€šè¿‡è°ƒèŠ‚å·¨å™¬ç»†èƒåŠŸèƒ½ï¼Œåˆ©ç”¨ CEL å¢å¼º M1 å·¨å™¬ç»†èƒæ¥æºå¤–æ³Œä½“å¯¹ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„å…ç–«æ²»ç–—</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320108" target="_blank" rel="noopener noreferrer">GSE320108 å°†æ‹·è´æ•°ã€ç”²åŸºåŒ–å’Œèåˆæ£€æµ‹æ•´åˆåˆ°ä¸€æ¬¡æ£€æµ‹ä¸­ï¼šä¸€ç§ç”¨äºå„¿ç«¥å’Œæˆäººç½•è§è‚¿ç˜¤è¯Šæ–­çš„çº³ç±³å­”æµ‹åºæ–¹æ³•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312326" target="_blank" rel="noopener noreferrer">GSE312326 DKC1 é€šè¿‡å¤±è°ƒé˜è„‚ç”Ÿç‰©åˆæˆä¿ƒè¿›ç»“ç›´è‚ ç™Œè¿›å±•å’Œæ²»ç–—è€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320378" target="_blank" rel="noopener noreferrer">GSE320378 roX RNA ç¼ºå¤±å¯¼è‡´çš„å‰‚é‡è¡¥å¿ç¼ºé™·å¯é€šè¿‡é‡æ–°æ ¡å‡† X/å¸¸æŸ“è‰²ä½“åŒ–å­¦è®¡é‡å¾—åˆ°æŒ½æ•‘ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320376" target="_blank" rel="noopener noreferrer">GSE320376 roX RNA ç¼ºå¤±å¯¼è‡´çš„å‰‚é‡è¡¥å¿ç¼ºé™·å¯é€šè¿‡é‡æ–°æ ¡å‡† X/å¸¸æŸ“è‰²ä½“åŒ–å­¦è®¡é‡æ¯”æ¥æŒ½æ•‘ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307263" target="_blank" rel="noopener noreferrer">GSE307263 äººç±»é«“ç³»å‘è‚²é©±åŠ¨å¤§è„‘ç¯å¢ƒä¸­çš„åˆ†åŒ–æ½œèƒ½ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307262" target="_blank" rel="noopener noreferrer">GSE307262 äººç±»é«“ç³»å‘è‚²é©±åŠ¨å¤§è„‘ç¯å¢ƒä¸­çš„åˆ†åŒ–æ½œèƒ½ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301256" target="_blank" rel="noopener noreferrer">GSE301256 å¢å¼ºçš„çº¿ç²’ä½“è‡ªå™¬é€šè¿‡æ¢å¤ä¸Šçš®ç»†èƒä»£è°¢åŠŸèƒ½ä¿ƒè¿›è‚ºéƒ¨ä¿®å¤å’Œå†ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299717" target="_blank" rel="noopener noreferrer">GSE299717 äººç±»é«“ç³»å‘è‚²é©±åŠ¨å¤§è„‘ç¯å¢ƒä¸­çš„åˆ†åŒ–æ½œèƒ½ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295598" target="_blank" rel="noopener noreferrer">GSE295598 æµæ„Ÿæ„ŸæŸ“åè‚ºæ³¡ II å‹ç»†èƒçš„æ—¶é—´åºåˆ— RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289669" target="_blank" rel="noopener noreferrer">GSE289669 MEK/ERKä¿¡å·é€šè·¯é˜»æ–­H3K9me3å¼‚æŸ“è‰²è´¨çš„å½¢æˆï¼Œä»è€Œä¿ƒè¿›äººç±»ä¸­èƒšå±‚å’Œå†…èƒšå±‚çš„åˆ†åŒ–ã€‚[RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289666" target="_blank" rel="noopener noreferrer">GSE289666 MEK/ERKä¿¡å·é€šè·¯é˜»æ–­H3K9me3å¼‚æŸ“è‰²è´¨çš„å½¢æˆï¼Œä»è€Œå¢å¼ºäººç±»ä¸­èƒšå±‚å’Œå†…èƒšå±‚çš„åˆ†åŒ–ã€‚[ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE223315" target="_blank" rel="noopener noreferrer">GSE223315ï¼šæºå¸¦Cysltr1ç¼ºé™·å°é¼ çš„EMT6è‚¿ç˜¤ç¥–ç»†èƒå’Œé«“ç³»ç»†èƒçš„å•ç»†èƒRNAè¡¨è¾¾æ•°æ®</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320427" target="_blank" rel="noopener noreferrer">GSE320427 ç»µç¾Šå•ç»†èƒè½¬å½•ç»„å¯¹ç§°æ€§ç ´ç¼ºå›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316009" target="_blank" rel="noopener noreferrer">GSE316009 é€šè¿‡æŠ‘åˆ¶USP7å¯¼è‡´éç»å…¸PRC1.1å¤åˆç‰©ä¸ç¨³å®šï¼Œä»è€Œè¯±å¯¼ç¥ç»æ¯ç»†èƒç˜¤ç¥ç»å…ƒåˆ†åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312830" target="_blank" rel="noopener noreferrer">GSE312830 CRYPTID-exonï¼šä» RNA-seq æ•°æ®ä¸­ç®€åŒ–éšè”½å¤–æ˜¾å­çš„æ£€æµ‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311135" target="_blank" rel="noopener noreferrer">GSE311135 å·¨å™¬ç»†èƒå¯¹çƒå­¢å­èŒçš„åå™¬ä½œç”¨ä¿ƒè¿›å…¶åˆ†åŒ–ä¸ºå¯„ç”Ÿå‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310927" target="_blank" rel="noopener noreferrer">GSE310927 PRMT5æŠ‘åˆ¶å¼•å‘åŠŸèƒ½æ€§ATMç¼ºé™·å¹¶ä½¿èƒ°è…ºç™Œå¯¹CHK1é˜»æ–­æ•æ„Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301413" target="_blank" rel="noopener noreferrer">GSE301413 å‘ç°ä¸€ç§å¯¹è¡€æ¶²æ¶æ€§è‚¿ç˜¤å…·æœ‰å¼ºæ•ˆæŠ—ç™Œæ´»æ€§çš„æ—ç³»åŒæºé€‰æ‹©æ€§p300è›‹ç™½é™è§£å‰‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299479" target="_blank" rel="noopener noreferrer">GSE299479 è‚ºç±»å™¨å®˜æ¨¡å‹å±•ç¤ºäº†ç»„æˆé©±åŠ¨çš„ä¸Šçš®å¯å¡‘æ€§å’Œå…ç–«æåŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295985" target="_blank" rel="noopener noreferrer">GSE295985 LGR5+éšçªåŸºåº•æŸ±çŠ¶ç»†èƒä¸­è¯±å¯¼çš„å¼‚å¸¸NOTUM+ç¨‹åºç»´æŒäº†ç»“ç›´è‚ ç™Œä¸­çš„å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288838" target="_blank" rel="noopener noreferrer">GSE288838 é«˜åˆ†è¾¨ç‡æŸ“è‰²è´¨å›¾è°±æ˜¾ç¤ºï¼ŒCTCF å°†å‡æ•°åˆ†è£‚ç¯é”šå®šåˆ°æŸ“è‰²ä½“è½´ä¸Šã€‚[Hi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228867" target="_blank" rel="noopener noreferrer">GSE228867 å¯¹ç…§ siRNA å’Œ PHGDH-siRNA å¤„ç†çš„äººç±»æ°¸ç”ŸåŒ–è¡¨çš®ç»†èƒ (HaCaT ç»†èƒ) çš„è¡¨è§‚åŸºå› ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309203" target="_blank" rel="noopener noreferrer">GSE309203 ZNF200 ä¸ DDX17 ç›¸äº’ä½œç”¨ï¼Œè°ƒæ§ RBP-J çš„è½¬å½•æ´»æ€§ã€‚[ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308112" target="_blank" rel="noopener noreferrer">GSE308112 ZNF200 ä¸ RBP-J å¯åŠ¨å­åŒºåŸŸçš„ DDX17 ç›¸äº’ä½œç”¨ï¼Œä»è€Œè°ƒèŠ‚ RBP-J çš„è½¬å½•æ´»æ€§ã€‚[ATAC-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307595" target="_blank" rel="noopener noreferrer">GSE307595 H1299 ç»†èƒç³»ä¸­ ZNF200 RNA-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320415" target="_blank" rel="noopener noreferrer">GSE320415 èŠè¯ç±½æ²¹é€šè¿‡æŠ‘åˆ¶PI3K/Akt/mTORå’ŒNF-ÎºBä¿¡å·é€šè·¯ç¼“è§£UVBè¯±å¯¼çš„è§’è´¨å½¢æˆç»†èƒç‚ç—‡ã€æ°§åŒ–åº”æ¿€å’Œå…‰è€åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE320026" target="_blank" rel="noopener noreferrer">GSE320026 è›‹ç™½è´¨ç¨³æ€æ£€æŸ¥ç‚¹æ§åˆ¶ EGFR ç¨³å®šæ€§å’Œç»†èƒé€‚åº”æ€§ï¼Œç”± lncRNA å®šä¹‰ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316115" target="_blank" rel="noopener noreferrer">GSE316115 RNA-seq åˆ†æ E18.5 å°é¼ èƒšèƒè‚ºæ­ç¤º Svep1 æ•²é™¤èƒšèƒä¸­è‚ºæ³¡æˆç†Ÿå’Œæ°”é“åˆ†åŒ–å—æŸ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308447" target="_blank" rel="noopener noreferrer">GSE308447 è‚¾ç›‚è‚¾ç‚å¯é™ä½è¡€æ¸…èƒ†å›ºé†‡å¹¶å‡è½»åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–çš„ä¸¥é‡ç¨‹åº¦ï¼Œå³ä½¿å­˜åœ¨å…¨èº«æ€§ç‚ç—‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290690" target="_blank" rel="noopener noreferrer">GSE290690 E3æ³›ç´ è¿æ¥é…¶HUWE1çš„ç¼ºå¤±ä¼šæŸå®³Krasè¯±å¯¼çš„è‚ºè…ºç™Œè‚¿ç˜¤å‘ç”Ÿå¹¶è¯±å¯¼è¡°è€è¡¨å‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290688" target="_blank" rel="noopener noreferrer">GSE290688 ä¸ƒå¶è‹·é¶å‘æ–‘é©¬é±¼å¹¼ä½“ä¸­çš„ Keap1/Nrf2/ARE ä¿¡å·é€šè·¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290687" target="_blank" rel="noopener noreferrer">GSE290687 E13.5 å¯¹ç…§ç»„å’Œ Isl1 cKO è§†ç½‘è†œçš„ RNA-Seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284673" target="_blank" rel="noopener noreferrer">GSE284673 L-äº®æ°¨é…¸æ‘„å–æŠ‘åˆ¶å‰‚å¯¹ç»“æ ¸åˆ†ææ†èŒmc2 6206å…¨åŸºå› ç»„è½¬å½•ç»„è°±çš„å½±å“</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-27 21:48</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>